Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Gradhand

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2009
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneGurinder Singh Atwal, Tomas Kirchhoff, Elisabeth E Bond, et al.
Frontiers in Immunology|February 18, 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcomaLaura M Moser, Catrin Heim, Sebastian E Koschade, et al.
Blood Advances|April 8, 2024
Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3Deniz Y Dogan, Eugen I Urzica, Isabelle Hornung, et al.
Frontiers in Immunology|September 4, 2023
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcomaCatrin Heim, Laura M Moser, Herman Kreyenberg, et al.
Nature Communications|September 11, 2024
The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumanniiChun Kew, Cristian Prieto-Garcia, Anshu Bhattacharya, et al.
Cancer Research|November 19, 2010
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivityJessika Wynendaele, Anja Böhnke, Eleonora Leucci, et al.
Cancer Research|February 2, 2022
Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes MetastasisEiman Elwakeel, Mirko Brüggemann, Jessica Wagih, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2024
From rare events to systematic data collection: the RESCUED registry for sudden cardiac death in the young in GermanyRenaldas Barkauskas, Tina Jenewein, Stefanie Scheiper-Welling, et al.
JCI Insight|October 5, 2023
Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumorsGhada M H Abdel-Salam, Susanne Hellmuth, Elise Gradhand, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Proceedings of the National Academy of Sciences of the United States of America|June 6, 2009
Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogeneGurinder Singh Atwal, Tomas Kirchhoff, Elisabeth E Bond, et al.
Frontiers in Immunology|February 18, 2025
CAR-CIK vs. CAR-T: benchmarking novel cytokine-induced killer cells as solid tumor immunotherapy in ErbB2+ rhabdomyosarcomaLaura M Moser, Catrin Heim, Sebastian E Koschade, et al.
Blood Advances|April 8, 2024
Hemojuvelin-mediated hepcidin induction requires both bone morphogenetic protein type I receptors ALK2 and ALK3Deniz Y Dogan, Eugen I Urzica, Isabelle Hornung, et al.
Frontiers in Immunology|September 4, 2023
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcomaCatrin Heim, Laura M Moser, Herman Kreyenberg, et al.
Nature Communications|September 11, 2024
The aryl hydrocarbon receptor and FOS mediate cytotoxicity induced by Acinetobacter baumanniiChun Kew, Cristian Prieto-Garcia, Anshu Bhattacharya, et al.
Cancer Research|November 19, 2010
An illegitimate microRNA target site within the 3' UTR of MDM4 affects ovarian cancer progression and chemosensitivityJessika Wynendaele, Anja Böhnke, Eleonora Leucci, et al.
Cancer Research|February 2, 2022
Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma Growth but Promotes MetastasisEiman Elwakeel, Mirko Brüggemann, Jessica Wagih, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2024
From rare events to systematic data collection: the RESCUED registry for sudden cardiac death in the young in GermanyRenaldas Barkauskas, Tina Jenewein, Stefanie Scheiper-Welling, et al.
JCI Insight|October 5, 2023
Biallelic MAD2L1BP (p31comet) mutation is associated with mosaic aneuploidy and juvenile granulosa cell tumorsGhada M H Abdel-Salam, Susanne Hellmuth, Elise Gradhand, et al.
Virchows Archiv : an International Journal of Pathology|April 2, 2022
Organ manifestations of COVID-19: what have we learned so far (not only) from autopsies?Danny Jonigk, Christopher Werlein, Till Acker, et al.
Pageof 4